A non-steroidal anti-inflammatory drug (NSAID) containing diclofenac sodium, designed for slow-release pain relief and inflammation reduction.
Round, pink, film-coated tablets with beveled edges and shallow convex faces.
Diclofenac sodium, 100 mg per tablet.
Inhibits the enzyme cyclo-oxygenase, reducing prostaglandin and thromboxane production, thereby decreasing pain and swelling.
One 100 mg tablet orally once a day for adults.
Swallowed whole, preferably with food.
Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout, post-surgical pain.
Known hypersensitivity to diclofenac sodium, asthma/urticaria/rhinitis with aspirin/NSAID use, active/suspected peptic ulcer/gastrointestinal bleeding, bone marrow depression.
Nausea, headaches, diarrhea, epigastric pain, anorexia, dyspepsia, flatulence, abdominal cramps, vertigo, dizziness.
Yes, gastrointestinal toxicity (bleeding, ulceration, perforation) can occur at any time.
Skin rashes, central nervous system effects, kidney problems, liver effects, blood disorders, hypersensitivity reactions, cardiovascular effects, severe cutaneous reactions, hair loss, bullous eruptions, erythema multiforme, photosensitivity.
Yes, including lithium, digoxin, methotrexate, other NSAIDs, cyclosporine, quinolone antibiotics, potassium-sparing diuretics, anticoagulants, antidiabetic agents.
Gastrointestinal symptoms, central nervous system effects, renal effects, potentially serious effects like gastrointestinal hemorrhage, acute renal failure, convulsions, coma.
Seek medical attention immediately. Gastric lavage and activated charcoal may be used.
History of gastrointestinal ulceration, haematemesis, or melaena, ulcerative colitis, Crohn's disease, haematological abnormalities, bleeding diathesis, elderly patients, renal/hepatic impairment, hepatic porphyria, dizziness/central nervous system disturbances, restricted sodium intake, frail/low-body weight patients.
No.
Not advisable.
Below 25°C (77°F), protected from moisture.